Young cancers and mRNA

Colon cancer Breast, prostate, lung, bowel, melanoma, kidney, lymphoma Cause of cancer deaths, lung bowel US data, 10.5% of newly diagnosed colorectal cancers now occur in people younger than 50 Expected to rise to 15% by 2030 https://www.cancer.org/cancer/types/colon-rectal-cancer/causes-risks-prevention/risk-factors.html Colorectal cancer is rising among people who are younger than age 50, and the reason for this remains unclear. https://pmc.ncbi.nlm.nih.gov/articles/PMC9177054/ Index of suspicion at younger age Anaemia, (red flag), SOBE, fatigue, pallor Abdominal pain, bloating Diarrhoea or constipation Change in normal bowel habit, (looser, more or less often), 3 weeks PR bleed, mixed, streaked, dark and tarry Pencil stools Feeling of fullness after passing stool Straining Abdo or back passage pain Lumps or obstruction Weight loss DVT Aetiology Obesity Physical activity DM2 Diet Microbiome, probiotics, prebiotics Vitamin D Smoking Alcohol Microplastics Personal and family history Adenomatous polyps Inflammatory bowel disease Lynch syndrome, hereditary non-polyposis colon cancer or (HNPCC) mRNA injections Rates of Colorectal and Other Cancers Are Rising in Young Adults, Puzzling Researchers https://jamanetwork.com/journals/jama/fullarticle/2834865?guestAccessKey=4f8a586a-606a-42e6-87af-bf379c315f4b&utm_medium=email&utm_source=postup_jn&utm_campaign=article_alert-jama&utm_content=olf-tfl_&utm_term=053025 Incidence of 14 cancer types increased among people younger than 50 years. 9 of those cancer types, including colorectal cancer and breast cancer, also increased in some over 50s. Factors Increased imaging But, many early-onset colorectal tumors diagnosed after symptoms Hyuna Sung, cancer surveillance research, American Cancer Society “Given that similar trends have been observed in the US and many other countries, it’s crucial for researchers to address how much of this is driven by shifts in risk factors versus changes in diagnostic practices,” 2024 report https://www.nboca.org.uk/wp-content/uploads/2024/02/NBOCA-SotN.pdf 38,604 patients New diagnosis 2021 to 2022 = 35,779 2022 to 2023 = 38,604 By October 2020, monthly diagnoses had returned to pre-pandemic levels, from April 2021 the number of monthly diagnoses continued to rise. The total number of patients diagnosed with colorectal cancer during 2021/22 surpassed annual figures prior to the COVID-19 pandemic. 2025 Report https://rcs-ceu.shinyapps.io/NBOCA/ https://www.nboca.org.uk/wp-content/uploads/2025/01/NBOCA-SotN-Patient-Report-2024_v1.0_09.01.25.pdf The potential for mRNA vaccines to cause cancer Theoretical mechanisms DNA Integration mRNA or fragments, reverse transcriptase, potentially disrupting tumour suppressor genes or activating oncogenes DNA contamination, integrate into the genome Contaminants in Vaccine Production Pfizer COVID-19 modRNA vaccines also contained an SV40 Inactivated tumour suppressor genes, p53 and Rb, promoting unchecked cell growth Prolonged Spike Protein Expression N1-methyl-pseudouridine-modified mRNA encoding the SARS-COVID-19 Spike protein Lipid nanoparticle (LNP) delivery to stem cells Sustained spike protein production, induce chronic inflammation, disrupt cellular repair mechanisms. Immune Suppression or Dysregulation Molecular Mimicry, Autoimmunity, inflammation Alter regulatory T-cell function, (potentially allowing pre-existing cancers to progress). (If the spike protein shares epitopes with tumour suppressor proteins) Learn more about your ad choices. Visit megaphone.fm/adchoices